Orion Market Research Report Drug Discovery Market | Page 2

recommendations, market estimations, market determinants, key company analysis, market insights,
company profiling, market segmentation, geographical analysis and analyst insights.
“The rising prevalence of health disorders such as genetic disorders, nervous system disorders,
cardiovascular diseases, diabetes, and cancer are creating demand for drug discovery market. Cancer have
major impact on global economies boosting the growth of drug discovery and development. According to
National Cancer Institute, in 2016, a total of 1,685,210 new cancer cases and 595,690 deaths from cancer
occur in the US. In addition, diabetes mellitus is chronic disease associated with severe life-long conditions
including nerve damage, kidney diseases, CVDs, and eye diseases, that require intensive monitoring and
control. The partial or completely decrease in the production of insulin and secretion by pancreatic beta
cells is the reason for the diabetes to be caused. With this increasing prevalence, the market players are
focused on the development of new drugs to improve the quality of life of the people. The market players
hold a robust pipeline for new products. For example: some of the drugs that are in development by the
company Evotec includes: EVT770 for type 1 and type 2 diabetes; CureNephron for chronic kidney disease
and CureBeta for type 1 and type 2 diabetes.”
Browse the full report on Drug Discovery Market by Type (Pharmacogenomics, High Throughput
Screening, Genomics, Bioinformatics, Biochips, Nanotechnology, Others), by End User (Pharmaceutical
Companies, Biopharmaceutical Companies, Biotech Companies, Research Institutes) – Global Trends,
Market
Size,
Share,
Growth,
Research
and
Forecast
2019-2025
at:
https://www.omrglobal.com/industry-reports/drug-discovery-market/
The global drug discovery market is geographically divided among four major regions – North America,
APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow
at a stable CAGR. North American market is driven by due to the technological advancement in
biotechnology and genomics and increasing investment in the healthcare infrastructure. Asia Pacific
market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023.
The rising demand for novel drug discovery technologies in the APAC region due to rising population is
backing the growth of the market in APAC region.
Market Segmentation
•
•
Drug Discovery Market by Type
Drug Discovery Market by End User
Region Covered
•
•
•
•
North America (US and Canada)
Europe (UK, Germany, France, Spain, and Italy)
Asia-Pacific (China, India, South Korea, and Japan)
Rest of the World (Middle East & Africa and Latin America)